← Leaderboards
Ebrahim Versi
Dmk Pharmaceuticals, Inc.
$546,910
Attributed
$546,910
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300.8K · FY2020–22$500K$375K$250K$125K$0
'20
'21
'22
Funding mix
By agency
NIH$546,910 · 2
By mechanism
R41$300,848 · 1
R43$246,062 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Mediation”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediationMorphineFaceLifeMedication-Assisted TreatmentMethadoneEffective TherapyEndorphinsHealth ProfessionalKappa Opioid ReceptorsActive ComparatorMedical StaffAgonistBuprenorphineAmericanCessation Of LifeClinical DevelopmentAdherenceAnimal ExperimentsCravingAbstinenceIntentionDoseMorphine Dependence
Grant awards (3)
Novel Bifunctional Small Molecule for the Treatment of Alcohol Use Disorder$300,848
R41 · FY2022 · AA · contact PI
Developing a Novel Mixed Opioid Agonist for the Treatment of OUD$55,000
R43 · FY2021 · DA · contact PI
Developing a Novel Mixed Opioid Agonist for the Treatment of OUD$191,062
R43 · FY2020 · DA · contact PI